News | Artificial Heart | March 18, 2016

Surgeons Perform North Texas’ First Total Artificial Heart “Bridge to Transplant”

Patient being kept alive with Total Artificial Heart receives donor heart transplant at Baylor University Medical Center at Dallas

Bryan Tyo, Baylor University Medical Center, bridge to transplant, Total Artificial Heart

March 18, 2016 — A surgical team at Baylor University Medical Center at Dallas successfully performed a heart transplant on a patient they were keeping alive with a total artificial heart.

The heart transplant was performed February 29. Weeks earlier, Baylor University Medical Center surgeons had removed the patient's damaged native heart and replaced it with a total artificial heart, a portable device that pumps blood throughout the body when both sides of the heart fail. The lifesaving technology is used as a "bridge" for patients who have end-stage biventricular heart failure and are waiting for a donor human heart or who are too sick to receive a transplant. It provides mechanical support until a donor human heart can be found.

Baylor University Medical Center at Dallas is the only hospital in the region to implant a total artificial heart and transition the patient to a successful heart transplant. The center joins a select group of high-volume transplant centers across the country to offer this service for patients.

"This is a special day for our patient and for our entire team," said Shelley Hall, M.D., chief of transplant cardiology, mechanical circulatory support and heart failure, Baylor University Medical Center at Dallas. "The patients who need this technology are the sickest of the sick and we are proud to offer our patients the latest tool to battle the nation's number one killer, heart disease."

The patient, 52-year-old Bryan Tyo, is a McKinney, Texas, resident who suffered a heart attack in January. The damage to his heart was so advanced that repair surgery and other mechanical assist devices could not help.

"Baylor now offers every option for our heart failure patients," said Themistokles Chamogeorgakis, M.D., associate surgical director of heart transplantation and mechanical circulatory support, Baylor University Medical Center at Dallas. "With fewer donor hearts becoming available, it is critical to offer these opportunities to bridge our patients to transplant."

Tyo is the first patient in North Texas to use the SynCardia Total Artificial Heart Freedom driver. It is a 13.5-pound portable unit that powered his artificial heart. The device replaced both failing ventricles and the four heart valves, restored an immediate flow of blood to the body and helped vital organs recover faster.

"I'm just thankful for this second chance at life," said Tyo. "My wife and I celebrated our 25th anniversary in October and I've got 25 more years to be with her, if she'll put up with me," he joked.

Heart disease is the No. 1 cause of death in the United States, claiming the lives of nearly 600,000 people a year. The bridge to transplant option is critical because only 2,200 donor hearts become available every year in the U.S.

While wait times can vary, Baylor University Medical Center has a median wait time of seven days for status 1A heart transplant patients from the time they are listed to transplant, one of the shortest wait times in the country.

For more information: www.syncardia.com

Related Content

BioCardia Announces 12-Month Results from TRIDENT Trial of Stem Cell Delivery System
News | Stem Cell Therapies| September 26, 2017
BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial, conducted by the...
CardiAMP Heart Failure Trial Design Presented at Texas Heart Institute Symposium
News | Heart Failure| September 25, 2017
BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial was presented during...
Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems| September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
Heart Failure Market to Surpass $16 Billion by 2026
News | Heart Failure| September 19, 2017
The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain, the U.K. and Japan is...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery| September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery| September 08, 2017
September 8, 2017 — ClearFlow Inc.
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

Feature | Left Atrial Appendage (LAA) Occluders| September 07, 2017
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Israeli Hospital Completes First Implant of CORolla Heart Failure Device
News | Heart Failure| September 05, 2017
Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from Israeli start-up company...
Overlay Init